Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doxa is a Swedish medtech company that specializes in the development and commercialization of bioactive ceramics based on its proprietary calcium aluminate technology. The company's flagship product line, Ceramir, is widely used in dentistry for permanent cementation of crowns and bridges, offering high biocompatibility and the ability to integrate with natural tooth structure. Doxa's materials are designed to mimic the properties of natural bone and teeth, promoting long-term stability and reducing sensitivity. While historically focused on dental applications, the company has explored the use of its bioceramic platform in orthopedic and other medical fields. In recent years, Doxa has also expanded its business model to include strategic investments in other sectors, such as construction and real estate, while maintaining its core life science operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doxa.